1. Identification of the source plants in honey by microscopic analysis of pollens. HKBU Faculty Research Grant. 2015. HK$143,000.

2. Correlating microscopic characteristics and biologically active components for evaluating the quality of Chinese medicinal materials. Hong Kong General Research Fund. 2015. HK$661,659.

3. Oral bioavailability of polysaccharides: an exploration of TLRs/Dectin-mediated phagocytosis to Ganoderma glucan GSP-2 by intestinal macrophages in vitro and in vivo. Hong Kong General Research Fund. 2015. HK$ 870,855.

4. Discovery of potential components attributed to pro-fibrotic activity of Aconitum carmichaeli Debx.. HKBU Faculty Research Grant. 2014. HK$127,500.

5. Standardization on the Nomenclatures of Chinese Medicinal Materials and Decoction Pieces Sold in Hong Kong. Innovation and Technology Fund. 2014. HK$ 416,000.

6. 《本草綱目》嶺南藥物考.國家自然科學基金.2014.人民幣:70萬.

7. HKCMMS Phase IX: Chemical assay of Polygonati Rhizoma and Homalomenae Rhizoma. Dept. of Health, HKSAR. 2014. HK$ 741,405.

8. Anticancer Mechanism of Alpiniae Officinarum Rhizoma against Gastric Cancer: from the Combinational Treatment of Curcumin and Quercetin. HKBU-FRG. 2014. HK$ 90,000.

9. 基於組織化學技術評價中藥柴胡"辨狀論質"的實質.國家自然科學青年基金.2014.人民幣:23萬.

10. Structural Modification and Biological Studies of the Antitumor Natural Products Miliusanes as Novel Cancer Therapeutic Agents. Hong Kong General Research Fund. 2014. HK$ 914,985.

11. Exhibition at InnoCarnival 2013: Matching Towards Modern Chinese Medicine: Conservation of Rare Chinese Medicines Resources and Exhibition of Modern Chinese Medicine Technology. Innovation and Technology Fund. 2013. HK$ 719,000.

12. Chemical and Biological Assessment of Herbal Decoction Dangui Buxue Tang using Hedysari Radix instead of Astragali Radix. HKBU-FRG. 2013. HK$ 90,000.

13. HKCMMS Phase VIII: Chemical assay of Hedysari Radix and Saussureae Involucratae Herba. Dept. of Health, HKSAR. 2013. HK$ 290,000.

14. Discovery of Aryl Naphthalide Lignans as Potential Anti-HIV Inhibitors from the Medicinal Plant Justicia gendarussa. Hong Kong General Research Fund. 2013. HK$1,268,250.

15. In Vivo Evaluation of Antitumor Efficacy of Plant-Derived Novel Natural Products Miliusanes. 2013. HK$1,284,701.

16. Laser Microdissection Analysis: Linking morphology and biochemistry to assess the quality of Chinese medicinal materials. Hong Kong General Research Fund. 2012. HK$ 843,720.

17. HKCMMS Phase VII: Chemical assay of Dendrobii Caulis and Dendrobii Officinalis Caulis. Dept. of Health, HKSAR. 2012. HK$ 260,000.

18. Platform Development for Quality Control Standards of Processed Chinese Materia Medica (Decoction Pieces) in the Hong Kong Market. Innovation and Technology Fund. 2012. HK$2,719,324.

19. HKCMMS Phase VI: Collection of CMM samples and Chemical assay of Carthami Flos. Dept. of Health, HKSAR. 2011. HK$ 251,000.

20. 應用鐳射顯微切割和液質聯用技術進行中藥組織化學研究.國家自然科學基金.2011.人民幣:65萬.

21. Mapping and extraction of active components in the stem of Sinomenium Acutum by combining laser microdissection with LC-MS. HKBU-FRG. 2011. HK$ 120,000.

22. Active Components Screening and Metabolism Study of Tibetan “Xuelianhua” (Saussurea laniceps). Research Grants Council (GRF). 2011. HK$ 751,019.

23. HKCMMS Phase VI: Collection of CMM samples and Chemical assay of Carthami Flos. Dept. of Health, HKSAR. 2011. HK$ 251,000.

24. Active Components Screening and Metabolism Study of Dragon’s Blood (Daemonorops Draco). HKBU-FRG. 2011. HK$ 120,000.

25. HKCMMS Phase V(A): Chemical assay of Perillae Caulis and Tribuli Fructus and HKCMMS Phase V(B): Chemical assay of Gleditsiae Spina and Piperis Longi Fructus. HKBU-FRG. 2011. HK$ 396,800.

26. Active Components Screening and Metabolism Study of Tibetan “Xuelianhua” (Saussurea laniceps). HKBU-FRG. 2010. HK$ 127,500.


版權所有 © 2015 香港浸會大學中藥標準化研究中心